Winning five core categories reaffirms Vetter as a trusted solution provider, particularly during globally challenging times

• Vetter reaffirms its high performance in customer-critical aspects
• Results reflect the positive experience of pharma and biotech companies in their daily work with the service provider — particularly during a pandemic
• Winning five awards mirrors the company’s core value of customer partnership

RAVENSBURG, GERMANY – Media OutReach – 19 February 2021 – Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), was granted the 2021 CMO Leadership Awards in five core categories — quality, expertise, compatibility, capabilities, and service. The award, now in its tenth year, was given by the leading trade press publication, Life Science Leader. Vetter was also the recipient of the award in a variety of categories in previous years.

“Yet again, Vetter is honored to be a winner of the CMO Leadership Awards as determined by our most important judges — our global customers,” said Vetter Managing Director Peter Soelkner. “This recognition is of particular importance given the challenging and turbulent times we are all experiencing with the global Covid-19 pandemic.” Carsten Press, Vetter’s Senior Vice President Key Account Management/Supply Chain Management/Marketing added, “Winning this award in five key categories is a direct reflection of what we strive to project to our customers. It further demonstrates our stable performance for them and especially their patients.”

Unlike other awards where an application process takes place, winners of the CMO Leadership Awards are chosen according to a customer ranking system. The basis for this is their hands-on experience with the service providers they have actually worked with. Using this method of validation means results are not able to be influenced in any manner. As such, the awards honor true customer performance and signify that winning companies have distinguished themselves through a leading level of support for the needs of their pharma and biotech customers.

“These past months reinforced the criticality of the services and partnership models provided by CDMOs to biopharma organizations of this size,” said Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma. “In fact, much of the drug development and manufacturing industry was sustained by reliable outsourcing in the face of a horrible pandemic. That reliability was a result of constant dedication to customers, and perhaps, one attribute above all — flexibility.”

Find the Vetter press kit and more background information here.

About the CMO Leadership Awards

The CMO Leadership Awards is an annual event now in its tenth year. In determining the award recipients, Life Science Leader teams up with Industry Standard Research (ISR) which conducted the research. For the 2021 award, more than 70 contract manufacturers were assessed by 23 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey. Participants were recruited from pharma and biotech companies of all sizes and screened for decision-making influence related to working with contract manufacturing partners. Respondents only evaluate those companies with which they have worked on an outsourced project within the past 18 months. Through this level of qualification, survey responses are based on actual involvement with contract manufacturers and clear experiential data.

About Vetter

Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria and the United States. Currently employing more than 5,000 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to social responsibility including environmental protection and sustainability. Learn more about Vetter at www.vetter-pharma.com.

SINGAPORE – Media OutReach – 19 February 2021 – Ohmyhome, homegrown one-stop Property Technology company, today officially launched its renovation services adding to the company’s suite of end-to-end services. From property searching to post-purchase services, Ohmyhome users can engage in quality and trusted services at every step of their housing journey without leaving the app.

Despite being one of the most important steps to achieving their dream homes, property owners still face perennial renovation woes such as unclear costing, inconsistent communication, delays, and renovation disputes. With high quality and consistency as its cornerstone, Ohmyhome Renovation effectively tackles these issues to deliver a simple, convenient, and quality experience for homeowners.

Ohmyhome has also assembled an experienced team of in-house interior designers, led by Demi Goh. A Top 15 finalist for Upcycled Architecture in the Fentress Global Challenge in 2014, Demi brings an impressive portfolio that emphasizes modern aesthetics with timeless and liveable design. Coupled with high quality materials from their partners, Ohmyhome Renovation is primed to exceed the discerning tastes of today’s condominium and landed property owners.

The Ohmyhome Renovation Experience

The process of engaging Ohmyhome renovation services is simple and transparent. When a customer expresses interest, they are put in touch with one of Ohmyhome’s in-house interior designers who will help translate the homeowner’s vision into concrete designs. Customers will receive a complimentary design proposal with fully transparent costing so that they will know exactly what they pay for. Once the proposal is confirmed, materials are ordered and the renovation is carried out with Ohmyhome’s trusted partners.

Renovation packages start from $9,888 and come with a one-year warranty.

With the official launch of Ohmyhome renovation, the proptech company extends its ethos of simplicity, convenience, and customer-oriented service to this important post-purchase process. Race Wong, co-Founder and CPO of Ohmyhome, shared “Renovation is an integral step to turning a house into a home, every corner matters to us and customer satisfaction is paramount. That’s why we’ve gathered experienced in-house design and project management teams along with a network of trusted and reliable partners so that every renovation project will be seamless, timely, and of the highest quality. At Ohmyhome Renovation, our business is making your dream home into a reality”.

To make an appointment for Ohmyhome renovation services call the hotline at 6886 9009, or visit https://renovation.ohmyhome.com/en-sg/

Rigorous planning and testing were undertaken by DHL to ensure supply chains support the vaccine’s stringent temperature requirements

KUALA LUMPUR, MALAYSIA – Media OutReach – 21 February 2021 – DHL Express, the world’s leading express service provider has successfully delivered the first batch of COVID-19 vaccines to Malaysia today. From door-to-door in just three days, DHL Express worked with Malaysia Aviation Group’s cargo subsidiary MABkargo Sdn. Bhd. (MASkargo) to fly the vaccines in and subsequently arranged for it to be sent directly to designated facilities across Kuala Lumpur.

DHL Express delivers first batch of COVID-19 vaccines to Malaysia

“In the past year, our teams across the world have truly embodied the As One spirit, coming together to deliver personal protective equipment, medical necessities and daily essentials to communities in need. We have now come full circle to elevate our purpose of connecting people and improving lives with the delivery of the COVID-19 vaccines to countries everywhere including the very first of shipments to Middle East, and now to Malaysia,” said Ken Lee, CEO, DHL Express Asia Pacific.

“We are proud to have the opportunity to make a difference and I can assure you that no effort is spared in ensuring that our well-established DHL Medical Express solution adhere to the stringent requirements of speed, quality, security and reliability when it comes to transporting these precious cargo,” he added.

One of the key challenges faced in the shipment of the COVID-19 vaccine is the stringent temperature requirements of the vaccine. The vaccine was delivered in specially designed thermal shipper packaging customised by the manufacturer. Each shipment was packed with dry ice to regulate the temperature, enabling its use in locations that lack the physical infrastructure to otherwise maintain the required temperature. Temperature trackers equipped with sophisticated GPS technology are also packed within each thermal shipper box to provide full visibility throughout the shipment’s entire journey.

“As COVID-19 continues to devastate lives and livelihoods, the vaccines represent hope for a better 2021,” said Julian Neo, Managing Director of DHL Express Malaysia and Brunei. “Organising their distribution to so many people in such a short time will be an extremely complex operation that we are well-equipped and proud to contribute to. Since the onset of the pandemic, DHL Express has leveraged our broad experience and expertise to help maintain the integrity of the healthcare supply chain, ensuring vital supplies and protective equipment reach communities and medical stakeholders in need.”

More than 9,000 life sciences and healthcare specialists work across DHL’s dedicated global network so that pharmaceutical, medical devices, clinical trials and research organisations, wholesalers and distributors, as well as hospitals and healthcare providers are connected across the value chain and through digitalisation, from clinical trials to point of care, and every step in between.

DHL’s portfolio for the healthcare industry includes 150+ pharmacists, 20+ clinical trials depots, 100+ certified stations, 160+ GDP-qualified warehouses, 15+ GMP-certified sites, 135+ medical express sites, and a time-definite international express network covering over 220 countries and territories.

On a global scale, logistics providers are challenged to establish medical supply chain rapidly to deliver vaccines of unprecedented amount of more than 10 billion doses worldwide–also in regions with less developed logistics infrastructures, where approximately 3 billion people live. To provide global coverage over the next two years, DHL estimated in its vaccine logistics whitepaper that up to 200,000 pallet shippers and 15 million cooling boxes as well as 15,000 flights will be required across the various supply chain setups.

DHL – The logistics company for the world

DHL is the leading global brand in the logistics industry. Our DHL divisions offer an unrivalled portfolio of logistics services ranging from national and international parcel delivery, e-commerce shipping and fulfillment solutions, international express, road, air and ocean transport to industrial supply chain management. With about 380,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global sustainable trade flows. With specialised solutions for growth markets and industries including technology, life sciences and healthcare, engineering, manufacturing and energy, auto-mobility and retail, DHL is decisively positioned as “The logistics company for the world”.

DHL is part of Deutsche Post DHL Group. The Group generated revenues of more than 63 billion euros in 2019. With sustainable business practices and a commitment to society and the environment, the Group makes a positive contribution to the world. Deutsche Post DHL Group aims to achieve zero-emissions logistics by 2050.